These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10661919)

  • 1. Senior moments.
    Gorman C
    Time; 1999 Nov; 154(19):158. PubMed ID: 10661919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Memory: therapeutic approach. Clinical evaluation].
    Pasquier F
    Therapie; 2000; 55(4):513-9. PubMed ID: 11098729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of normal and pathologic memory impairment in later life.
    Crook TH
    Semin Neurol; 1989 Mar; 9(1):20-30. PubMed ID: 2569225
    [No Abstract]   [Full Text] [Related]  

  • 4. Inclusion and exclusion clinical criteria to form homogeneous groups of patients in the therapeutic trials of a memory enhancing drug.
    Piette F
    Arch Gerontol Geriatr Suppl; 1989; 1():195-200. PubMed ID: 2757732
    [No Abstract]   [Full Text] [Related]  

  • 5. Losing your mind? Memory lapses are usually normal, but some may signal deeper problems.
    Herbert W
    US News World Rep; 1999 Jul; 127(4):44-51. PubMed ID: 10539694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of clinical trials in memory clinics].
    Allain H; Baudoin V; Dubois B; Forette F
    Therapie; 1997; 52(5):487-9. PubMed ID: 9501583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors. Comparing the options for mild-to-moderate dementia.
    Conn DK;
    Geriatrics; 2001 Sep; 56(9):56-7. PubMed ID: 11582975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
    Unterbeck A
    Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
    [No Abstract]   [Full Text] [Related]  

  • 9. Rofecoxib in mild cognitive impairment.
    Ownby RL
    Curr Psychiatry Rep; 2006 Feb; 8(1):9-10. PubMed ID: 16513035
    [No Abstract]   [Full Text] [Related]  

  • 10. Mayo Clinic office visit. Mild cognitive impairment. An interview with Ronald Petersen, M.D., Ph.D.
    Petersen R
    Mayo Clin Womens Healthsource; 2006 Nov; 10(11):7-8. PubMed ID: 17047568
    [No Abstract]   [Full Text] [Related]  

  • 11. Toward optimal health: the experts discuss memory loss in aging women.
    Espino DV; Andel R
    J Womens Health (Larchmt); 2004 Oct; 13(8):856-62. PubMed ID: 15671701
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
    Crowell TA; Paramadevan J; Abdullah L; Mullan M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphatidylserine and memory disorders in the aged].
    Nerozzi D; Aceti F; Melia E; Magnani A; Marino R; Genovesi G; Amalfitano M; Cozza G; Murgiano S; De Giorgis G
    Clin Ter; 1987 Mar; 120(5):399-404. PubMed ID: 3034480
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication use in patients presenting to a rural and remote memory clinic.
    Steve TA; Kirk A; Crossley M; Morgan D; D'Arcy C; Biem J; Forbes D; Stewart N
    Can J Neurol Sci; 2008 Nov; 35(5):669-71. PubMed ID: 19235457
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
    Wong VS
    Neurology; 2007 Aug; 69(8):809; author reply 809-10. PubMed ID: 17709718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Old myths hinder therapy. Memory disorders are not an expression of "normal" aging].
    Kötter HU; Hampel H
    MMW Fortschr Med; 2000 Jun; 142(25):35-6. PubMed ID: 10920666
    [No Abstract]   [Full Text] [Related]  

  • 17. Society for Neuroscience--37th Annual Meeting.
    McGee V
    IDrugs; 2008 Jan; 11(1):1-3. PubMed ID: 18175249
    [No Abstract]   [Full Text] [Related]  

  • 18. Mere forgetfulness or early Alzheimer's disease?
    Rossor MN; Fox NC
    Ann Neurol; 2000 Apr; 47(4):419-20. PubMed ID: 10762150
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.
    Diamond EL; Miller S; Dickerson BC; Atri A; DePeau K; Fenstermacher E; Pihlajamäki M; Celone K; Salisbury S; Gregas M; Rentz D; Sperling RA
    Neurology; 2007 Sep; 69(13):1331-41. PubMed ID: 17893294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A logical approach to the clinical assessment of cerebro-active drugs.
    Wertheimer J
    Arch Gerontol Geriatr Suppl; 1989; 1():201-5. PubMed ID: 2757733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.